Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine N-butylbromide for shortening the active phase of labor in term pregnancy
PACTR202502489216837Phase 0Recruiting
- Sponsor
- Alfa Yusuf
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised trial in childbirth comparing Hyoscine N-butylbromide arm with Placebo arm (2 arms). Primary endpoint: Duration of active phase of first stage of labour. Started Sep 2024; status: recruiting.
02
Drugs
hyoscine butylbromide
03
Conditions
childbirth
Beyond the preview
Go deeper on PACTR202502489216837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502489216837.